Rezolute, Inc. current report, 07 January 2013

SEC Filing Summary: Fits My Style Inc. (8-K)

Business Context and Reporting Period

This Form 8-K was filed by Fits My Style Inc. on January 7, 2013. The filing serves as a Regulation FD disclosure regarding a significant corporate development involving a third party, AntriaBio, Inc.

Key Financial Metrics

The filing text does not provide specific financial data, including revenue, profit, cash flow, margins, debt, or liquidity metrics for Fits My Style Inc. or AntriaBio, Inc.

Material Changes and Corporate Actions

  • Asset Acquisition: AntriaBio, Inc. announced the acquisition of the assets of PR Pharmaceuticals, Inc.
  • Merger Intent: AntriaBio, Inc. announced its intention to merge with Fits My Style Inc.
  • Disclosure Status: The information is deemed "furnished" rather than "filed" under General Instruction B.2 of Form 8-K.

Guidance, Outlook, and Risks

The filing contains no management commentary, financial guidance, or specific risk factors beyond the standard Regulation FD disclaimer. The primary event is the announcement of the merger intention and asset acquisition.

Investor Verification Checklist

  • Verify the terms and status of the proposed merger between AntriaBio, Inc. and Fits My Style Inc.
  • Confirm the details of the asset acquisition of PR Pharmaceuticals, Inc. by AntriaBio, Inc.
  • Review the attached press release (Exhibit 99.1) for specific transaction terms not included in the 8-K body.
  • Check for subsequent filings regarding shareholder approval or regulatory clearance for the merger.